STESTERIS plc
Is it growing?
Growing: earnings up +25% year on year and operating margin widening (+2.2 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +12% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 18.9% now against 16.7% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is STE growing?
STERIS plc has grown revenue 8.9% a year over three years and 12% a year over five, with earnings per share compounding at 89%.
Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +12%
Revenue growth, 5-year rate · +8.9% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- +89%
Earnings per share, 3-year rate · revenue +8.9% · earnings outgrew revenue: margins or the share count worked for shareholders
- Years of annual history on file
- 10
Years of annual history on file · FY2017 to FY2026, as filed
Details›
- Revenue FY2022
- $4.22B
- Revenue FY2023
- $4.54B
- Revenue FY2024
- $5.14B
- Revenue FY2025
- $5.46B
- Revenue FY2026
- $5.94B
Annual income statements as filed with the SEC.